GRACE :: Lung Cancer

Search cancerGRACE.org

molecular diagnostics

Denise Brock

Molecular Diagnostics Testing and Next Generation Sequencing

Share
   

 

  
The Global Resource for Advancing Cancer Education (GRACE)
presents 
Molecular Diagnostic Testing and Next Generation Sequencing Webinar Series

Kurt Davies, PhD, Instructor with the University of Colorado Health Sciences Center – Department of Pharmacology, and Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine join GRACE to discuss Molecular Diagnostic Testing and Next Generation Sequencing.  This extremely informative (audio only) webinar series discusses cancer cell biology, targeted therapies, genetic testing, the importance of retesting in cases of resistance, and next generation sequencing.  


 

 

Cancer Cell Biology 101,  Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus  

Download Transcript Here

 


 

 

How Targeted Therapies Treat Cancer,  Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus   

Download Transcript Here


 

 

How it Works: Genetic Testing in Lung Cancer,  Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus   

Download Transcript Here


 

 

Resistance to Targeted Therapies, and the Importance of Retesting,  Presented by Kurtis Davies, PhD, University of Colorado Anschutz Medical Campus   

Download Transcript Here


 

Nirali Patel, MD

 

What is Next Generation Sequencing (NGS)?  Presented by Nirali Patel MD, Assistant Professor, Department of Pathology and Laboratory Medicine, UNC School of Medicine  

Download Transcript Here


Please feel free to offer comments and raise questions in our Discussion Forums.


GRACE would like to thank the following sponsors for their support of this program

 

Image result for boehringer ingelheim logo

Takeda Oncology

 


GRACE Video

Dr. David Spigel: Which Lung Cancer Patients Should We Be Doing Molecular Marker Testing For, and Should We Do “Reflex Testing”?

Share

Dr. David Spigel, Sarah Cannon Cancer Center, reviews which patients with lung cancer he feels should undergo molecular testing, as well as describing the potential value of immediate, reflex testing for molecular targets.


GRACE Video

Dr. Alan Sandler: Is There a Danger that the Latest Advances in Molecular Testing Are Only Available in Limited Specialty Settings?

Share

Dr. Alan Sandler, Oregon Health and Science University, describes how he sees very specialized molecular testing for lung cancer becoming increasingly available to oncologists seeing patients in the community setting.


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share

Subscribe to the GRACEcast Podcast on iTunes

Share

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243